Standard B-complex at 25-100 mg of each B (Pure Encapsulations B-Complex Plus or equivalent):

• Most reliable acute marker: bright yellow urine (riboflavin excretion) within 4-8 hours. Tells you it's absorbing.
• Subjective effect is mild and chronic, not acute. Most users in healthy non-deficient state report no felt acute effect from a single B-complex capsule. Over 2-4 weeks, ~30-40% of users report subtle improvements in mood, energy, mental clarity, especially under stress (work, training load, illness recovery). The other 60% report no felt effect.
• Strongest subjective signal in: previously low-intake populations (heavy alcohol use, restrictive diet, high training volume without nutritional support, chronic stress, post-illness recovery), MTHFR variant carriers (especially with mood/anxiety symptoms), and elderly.
• Methylated forms can feel different: A subset of users report acute energy + mood lift from methylfolate (especially MTHFR variants), occasionally accompanied by a paradoxical anxiety / agitation spike on first dose ("methylation overload" — anecdotal but commonly reported). Starting at quarter-dose and titrating up over 1-2 weeks usually resolves this.
• B6 (P5P) at >25 mg can produce vivid dreams in some users via increased serotonin/GABA synthesis — usually positive, occasionally disruptive.
• Niacin (not niacinamide) at >50 mg produces flush within 30 min — face/chest/arm warmth, redness, mild itch, lasting 30-60 min. Harmless but uncomfortable. Most B-complexes use niacinamide to avoid this.

• No tolerance to B-vitamin supplementation. These are cofactors and substrates, not receptor-targeting agents.
• No cycling needed. Continuous daily use is the right pattern. Body excretes excess water-soluble vitamins via urine; toxicity is essentially impossible at supplement doses for B1/B2/B5/B7/B9/B12 (B6 and high-dose niacin are exceptions).
• Reset / washout: No washout needed. If discontinuing, status simply returns to dietary baseline over 2-8 weeks (B12 has long half-life — months — due to liver storage; folate stores last 3-4 months; thiamine stores last 2-3 weeks).

Synergistic with

• alcar: ✅ ALCAR's acetyl-CoA mechanism intersects with B5 (CoA-SH) and B1 (PDH) substrate pools. B-complex provides substrate; ALCAR provides acetyl groups. Stack-clean.
• citicoline: ✅ Citicoline's Kennedy pathway (phosphatidylcholine biosynthesis) intersects with one-carbon metabolism (PEMT pathway) and methionine cycle. B-complex provides the methyl donors that feed PEMT and citicoline-related methylation. Stack-clean.
• n-acetyl-cysteine (NAC): ✅ Already in V4 (1200 mg/day). NAC provides cysteine for glutathione synthesis; B-complex provides B6 (CBS pathway, homocysteine → cysteine) + B9 + B12 (methionine cycle). Mechanistically complementary.
• TMG (trimethylglycine, betaine): ✅ Alternative methyl donor (BHMT pathway: betaine + homocysteine → methionine + dimethylglycine, B12-independent). Useful adjunct for MTHFR variants who need additional methylation support. Stack-clean.
• SAMe (S-adenosylmethionine): ✅ Direct methyl donor; B-complex maintains the methionine cycle to recycle SAH back to Met. Stack-clean. SAMe is expensive; B-complex is upstream support.
• DHA/omega-3 fish oil: ✅ Already in V4. Phospholipid synthesis (Wurtman triad) requires choline + uridine + DHA + adequate B-vitamin methylation status. Stack-clean.
• Choline / phosphatidylcholine / lecithin: ✅ Choline provides the BHMT methyl donor pathway as alternative to MTHFR. Often combined.
• Magnesium: ✅ Already in V4 (Mg glycinate + Magtein). Mg is cofactor for MTHF reductase indirectly; ATP-dependent reactions throughout one-carbon cycle require Mg. Stack-clean.
• Vitamin D3 + K2: ✅ Already in V4. Mechanism-orthogonal. Stack-clean.
• Caffeine + L-theanine: ✅ Mechanism-orthogonal. Stack-clean. B6 supports neurotransmitter synthesis that caffeine/theanine modulate.
• Modafinil: ✅ No PK interaction. B-complex supports neurotransmitter substrate that modafinil's increased cortical activity demands. Stack-clean for V5.
• Creatine: ✅ Already in V4. Creatine biosynthesis uses SAM (methylation cycle); B-complex provides the methyl donors. Mechanistically supportive.
• Iron (women, vegetarians): ✅ B-vitamins (especially B6, B9, B12, B2) support hematopoiesis; iron is the substrate for hemoglobin. Stack-clean.

Avoid stacking with

• High-dose B6 from multiple sources — if Dylan adds magnesium-B6 (some Mg formulations include B6 as cofactor), check total B6 intake to avoid chronic >100 mg/day.
• High-dose biotin from multiple sources — same logic; biotin in B-complex + biotin in hair/nail supplements + biotin in collagen powder can stack to lab-interfering levels.
• Folic acid + folinic acid + 5-MTHF simultaneously at high doses — redundant; pick one form (5-MTHF for MTHFR variants).
• Methotrexate (Rx) — methotrexate is a folate antagonist; folic acid + 5-MTHF supplementation can reduce methotrexate efficacy. Folinic acid (leucovorin) is the bypass-rescue used in oncology / RA / psoriasis. Discuss with prescriber.
• Levodopa (Parkinson's) — pyridoxine (B6) increases peripheral L-DOPA decarboxylation, reducing CNS L-DOPA bioavailability. Modern L-DOPA + carbidopa formulations mostly bypass this concern; still worth flagging.
• Phenytoin, phenobarbital, primidone (anticonvulsants) — these reduce serum folate; supplementation needed but high-dose folate may reduce anticonvulsant efficacy. Coordinate with prescriber.

Neutral / safe co-administration

• All current V4 stack items: NAC, magnesium glycinate, magnesium L-threonate, PS, curcumin, rhodiola, theanine, glycine, D3+K2, beta-alanine, vitamin C, fish oil, creatine, citicoline.
• All planned V5 additions: modafinil, bromantane, ALCAR, apigenin, taurine, astaxanthin, L-tryptophan, selegiline, Cerebrolysin (cycled).

• Methotrexate: Folate antagonist; folic acid / 5-MTHF supplementation reduces efficacy. Folinic acid is rescue.
• Levodopa (without carbidopa): B6 increases peripheral L-DOPA decarboxylation. Carbidopa-containing formulations mostly bypass.
• Phenytoin, phenobarbital, primidone, carbamazepine: Reduce serum folate; high-dose folate may reduce anticonvulsant efficacy.
• Metformin: Reduces B12 absorption (~20-30% over years). Long-term metformin users should supplement B12 and check serum B12 + MMA periodically. Common diabetes-care issue.
• PPIs (omeprazole, esomeprazole, pantoprazole, etc.): Reduce gastric acid → reduce B12 release from food protein → impair absorption over years. Long-term PPI users should supplement B12.
• H2 blockers (ranitidine, famotidine): Similar but milder than PPI effect.
• Cholestyramine, colestipol: Bile acid sequestrants reduce fat-soluble vitamin absorption (not directly relevant to water-soluble B-complex but often co-administered with multivitamins).
• Isoniazid (TB drug): Antagonizes B6; standard practice to co-administer pyridoxine 25-50 mg/day to prevent INH-induced peripheral neuropathy.
• Hormonal contraceptives: Mild reduction in B6, B9, B12 status over long-term use (mechanism unclear). Modest signal; B-complex supplementation is reasonable.
• Alcohol (chronic): Depletes B1, B6, B9 most prominently. Heavy drinkers should always be supplementing.
• Tetracyclines: B-complex containing iron or calcium may chelate; separate doses by 2 hours.
• Hydralazine: Antagonizes B6; may need supplementation.

MTHFR pathway recap

Methylenetetrahydrofolate (5,10-MTHF) → MTHFR enzyme + FAD cofactor → 5-MTHF (the active circulating form, methyl donor in the methionine cycle).

5-MTHF + Hcy → Met + THF (catalyzed by methionine synthase (MTR), with methylcobalamin (B12) as cofactor and MTRR as the recycling enzyme).

Met + ATP → SAM (S-adenosylmethionine, the universal methyl donor) → SAH (after donating methyl group) → Hcy → cycle continues.

Result: a healthy methylation cycle requires adequate B9 (5-MTHF substrate), B12 (methylcobalamin cofactor), B2 (FAD for MTHFR), B6 (P5P for the alternative trans-sulfuration pathway via CBS), and adequate amino acid + glycine + choline pools.

CBS pathway (alternative homocysteine clearance)

Hcy + serine → cystathionine → cysteine → glutathione (or H2S, taurine, etc.), catalyzed by CBS (cystathionine β-synthase) with P5P (B6) as cofactor.

CBS variants (e.g., rs5742905 / I278T): Most variants reduce CBS activity, leading to elevated homocysteine and reduced glutathione/cysteine production. Some "CBS upregulation" variants (the C699T + A360A "fast CBS" pattern often discussed in functional medicine) are largely myth — recent literature has not replicated the original claim, and the clinical phenotype assignments based on MTHFR + CBS combinations from 2010s-era functional medicine are not well-supported by current genetics. Treat the "CBS upregulation" model with skepticism; treat MTHFR variants as well-validated.

Practical decision tree for Dylan post-23andMe

• MTHFR C677T homozygous (TT) + low-normal homocysteine: Methylated B-complex (5-MTHF + methylcobalamin + P5P + riboflavin). STRONG-CANDIDATE. Consider TMG (trimethylglycine, separate compound) as additional methyl donor backup.
• MTHFR C677T heterozygous (CT) + normal homocysteine: Methylated B-complex is reasonable insurance. OPTIONAL-ADD → STRONG-CANDIDATE. Marginal but real benefit.
• MTHFR wildtype (CC) + normal homocysteine: Generic B-complex (folic acid + cyanocobalamin) is functionally equivalent. Methylated form is no harm but no real edge. OPTIONAL-ADD baseline insurance.
• MTHFR wildtype + elevated homocysteine (>10 µmol/L): Investigate other causes (B12 deficiency, B6 deficiency, kidney function, thyroid, lifestyle). B-complex still indicated.
• Vegan diet + any MTHFR status: STRONG-CANDIDATE for B12 (methylcobalamin or cyanocobalamin) at 500-1000 mcg/day minimum. B-complex covers this.
• Any pregnancy / preconception: STRONG-CANDIDATE for folate (methylfolate if MTHFR variant, folic acid otherwise) at 400-800 mcg/day.

Recommendation for Dylan: Pure Encapsulations B-Complex Plus, 1 cap AM with breakfast. ~$25-35/month at iHerb. Methylated forms hedge MTHFR uncertainty pre-23andMe; clean ingredient list; trusted brand. Alternative: Jarrow B-Right at half the cost for similar methylation coverage.

Total cost estimate: $15-35/month. Among the cheapest insurance interventions in the supplement space.

Baseline (before starting; relevant subset for Dylan's June 2026 panel)

• Homocysteine — most useful single marker. Optimal <7 µmol/L; functional <10 µmol/L; concerning >12 µmol/L. Already in Dylan's June 2026 panel context.
• Methylmalonic acid (MMA) — functional B12 marker; elevated in B12 deficiency before serum B12 drops. More sensitive than serum B12 alone.
• Holotranscobalamin (active B12) — fraction of B12 bound to TC2 and bioavailable. More functional than total B12.
• Serum B12 — standard but late marker; can be normal with functional deficiency.
• RBC folate — reflects 3-month folate status; better than serum folate.
• Plasma pyridoxal-5-phosphate (P5P) — direct B6 activity marker. Less commonly ordered.
• CBC with MCV — macrocytic anemia (MCV >100) suggests B12 or folate deficiency.
• TSH, free T3, free T4 — exclude thyroid causes of fatigue/cognitive symptoms before attributing to B-vitamin deficiency.
• CMP, lipid panel, hs-CRP — general baseline.

During use

• Subjective tracking: energy, mood, mental clarity, sleep, exercise recovery — track over 4-8 weeks.
• Bright yellow urine = absorption confirmation.
• 6-12 month recheck: homocysteine + MMA + B12 + RBC folate to confirm target levels.

Post-genotyping (Dylan ~June 5-15, 2026)

• MTHFR C677T + A1298C — primary decision-driver for methylated form vs generic.
• MTRR A66G, MTR A2756G, CBS variants — secondary.
• COMT V158M — modulates methyl donor demand.